Coherus Oncology Inc (CHRS)

Net Receivables

$14.25M

Quarterly · Period ending: · USD

CHRS logo

CHRS Net Receivables

Latest reported$14.25M
CHRS Quarterly Net Receivables ($0.00 → $14.25M)
High-resolution chart · PNG

CHRS net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Net Receivables — Quarterly (USD)
Period endingNet Receivables (USD)
14,253,000
22,510,000
18,418,000
250,496,000
119,639,000
62,436,000
122,334,000
198,800,000
313,568,000
284,145,000
260,522,000
216,511,000
141,308,000
101,458,000
109,964,000
91,186,000
115,711,000
117,039,000
123,022,000
136,346,000
141,825,000
140,410,000
157,046,000
160,707,000
172,486,000
167,450,000
141,992,000
89,646,000
77,385,000
46,476,000
0
0
0
0
0
0
0
26,000
1,859,000
419,000
419,000
1,195,000
1,560,000
540,000
1,454,000
2,015,000
4,232,000
0
0
261,000
385,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.